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Abstract: Two decades of pharmacologic research on the human capacity to implicitly acquire knowledge as well as  
cognitive skills and procedures have yielded surprisingly few conclusive insights. We review the empirical literature of 
the neuropharmacology of implicit learning. We evaluate the findings in the context of relevant computational models  
related to neurotransmittors such as dopamine, serotonin, acetylcholine and noradrenalin. These include models for   
reinforcement learning, sequence production, and categorization. We conclude, based on the reviewed literature, that one 
can predict improved implicit acquisition by moderately elevated dopamine levels and impaired implicit acquisition by 
moderately decreased dopamine levels. These effects are most prominent in the dorsal striatum. This is supported by a 
range of behavioral tasks in the empirical literature. Similar predictions can be made for serotonin, although there is yet a 
lack of support in the literature for serotonin involvement in classical implicit learning tasks. There is currently a lack of 
evidence for a role of the noradrenergic and cholinergic systems in implicit and related forms of learning. GABA modula-
tors, including benzodiazepines, seem to affect implicit learning in a complex manner and further research is needed.  
Finally, we identify allosteric AMPA receptors modulators as a potentially interesting target for future investigation of the 
neuropharmacology of procedural and implicit learning. 
Keywords: Implicit learning, procedural learning, neurotransmittors, neuromodulators, dopamine, serotonin, acetylcholine, 
noradrenalin, GABA, glutamate, NMDA, ampakines.  
1. INTRODUCTION 
  Everyday life provides many examples of complex be-
havior. One of the most intriguing complex behaviors is per-
haps language communication via  the exchange of (struc-
tured) sentences. This skill is learnt during early childhood, 
largely as a consequence of self-organized, non-supervised 
acquisition mechanisms, including implicit sequence learn-
ing and incidental learning [1]. The acquisition of complex 
knowledge structures, essentially without deliberate explicit 
strategies and supervised teaching, has been investigated 
under the umbrella term of implicit learning. Skill learning 
and procedural learning are related forms of learning and 
repetition priming (also called implicit memory) is likely to 
be related as well. The enterprise of finding the neurobi-
ological mechanisms underlying implicit learning is still in 
its infancy. Some progress has been made on localization of 
important brain circuitry supporting this type of learning [2], 
but which neurotransmitters are utilized in these circuits, as 
well as which functional role these play is largely unknown. 
  In general terms, implicit learning is “the process 
whereby a complex, rule-governed knowledge base is ac-
quired, largely without any requirements of awareness of 
either the process or the product of acquisition” [3]. More 
precisely, implicit learning has four characteristics: (1) no or  
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limited explicit access to the knowledge acquired and how it 
is put to use; (2) the acquired knowledge is more complex 
than simple associations (such as simple stimulus-response 
associations) or exemplar specific frequency-counts; (3) it is 
an incidental consequence of information processing and not 
explicit hypothesis testing and (4) it does not rely on declara-
tive memory mechanisms [2]. Implicit learning is typically 
investigated using stimuli such as patterns or structured se-
quences. 
  There is good evidence that the frontal cortex and the 
basal ganglia (fronto-striatal circuits) are involved in implicit 
learning in humans. This has been characterized in patient 
(lesion) studies [for reviews see e.g. 2, 4] and functional neu-
roimaging studies in healthy volunteers [5-7]. Likewise, 
there is empirical research showing that the prefrontal cortex 
is involved [4, 5, 8, 9]. The fact that implicit learning does 
not rely on declarative memory mechanisms (i.e., the medial 
temporal lobe, MTL, memory system) is evidenced by   
preserved implicit learning in amnesic patients [4, 10, 11]. 
There is little evidence that the MTL is engaged by implicit 
learning tasks [2, 4]. In contrast, in a recent study [12] the 
MTL was deactivated during an artificial grammar learning 
paradigm, an implicit learning task that we will describe be-
low. This is consistent with the view that implicit processing 
does not rely on declarative memory mechanisms that   
engage the MTL memory system. However, there is yet no 
detailed account of the characteristics of the learning mecha-
nisms involved in implicit learning, the nature of the knowl-
edge acquired, or how this knowledge is represented and   368    Current Neuropharmacology, 2010, Vol. 8, No. 4  Uddén et al. 
put to use, nor a detailed characterization of the neural   
processing infrastructure supporting these functions, for   
instance in terms of neurotransmittor and receptor systems  
[13]. 
  In this paper we review the neuropharmacology literature 
relevant to implicit learning in an attempt to characterize 
what is known about the neuropharmacology of implicit 
learning. We focus mainly on neuromodulators, which are 
neurotransmitters, typically with slow temporal characteris-
tics that induce temporally extended and non-local effects on 
synaptic transmission. In particular, we review the role of the 
four main neuromodulator systems in implicit learning: do-
pamine, serotonin, noradrenalin, and acetylcholine. Related 
studies on procedural and probabilistic learning are also con-
sidered. Since the functions of -aminobutyric acid (GABA) 
and allosteric -amino-3-hydroxy-5-methyl-4-isoxazolepro- 
pionic acid (AMPA) receptor modulators (ampakines) in 
implicit learning are likely to be relevant, we also review 
these systems. 
  The most well-studied implicit learning task is perhaps 
artificial grammar learning [AGL, for reviews see 14, 15]. 
The task consists of a learning or acquisition phase and a test 
phase. In the acquisition phase, participants are exposed to 
an acquisition set of symbol sequences generated from a 
formal grammar (i.e., a complex rule system), typically in a 
short term memory task. In the standard version, subjects are 
subsequently informed that the sequences were generated 
according to a complex set of rules and asked to classify 
novel sequences as grammatical or not, typically with the 
instruction to base their classification decisions on their   
immediate intuitive judgment (i.e., guessing based on   
“gut feeling”). It is a robust and well-replicated finding that 
subjects perform significantly above chance on this type of 
task [5, 9, 13, 15], and more so after several days of implicit 
acquisition [16, 17]. 
  Besides AGL, one of the most intensely investigated im-
plicit learning paradigms is the serial reaction time task 
(SRTT) [15, 18]. In the classical version of the SRTT, im-
plicit learning is inferred from faster reaction times when 
subjects respond to a fixed reoccurring sequence versus ran-
dom sequences. In this task, sequences are typically dis-
played as digit sequences, for example of the digits 1-4. Each 
digit corresponds to a button press so that 1 for example 
means “press the button under your index finger”, 2 means 
“press the button under your middle finger” and so on. In our 
example, the implicit knowledge would consist of the reoc-
curring sequence pattern 3-2-4-1 that makes response times 
faster compared to random sequences. Again, the partici-
pants typically report no or little awareness of their acquired 
knowledge. This paradigm has also been implemented for 
investigation in rodents but the validity of implicit learning 
in rodent research is still controversial [19]. There are sev-
eral proposals for how knowledge of sequence structure is 
acquired in animals, including the acquisition of stimulus–
response associations or more abstract representations [19]. 
Generally, the learning of sequences with a fixed order can 
be viewed as a special case of acquiring knowledge about 
more general structural regularities or temporal contingen-
cies in stimuli [2, 14]. 
  In Tulving’s organization of human memory and learning 
systems, he argues that procedural (or non-declarative) learn-
ing, lumping together motor and cognitive skills as well as 
simple conditioning and associative memories, is acquired 
by implicit processes [20]. We will review some tasks which 
are commonly conceptualized as procedural learning tasks, 
including problem solving puzzles like the Tower of Hanoi, 
London or Toronto [21], mirror reading/drawing, and track-
ing tasks. These tasks do require acquisition of complex se-
quenced behavior. Sequential learning is a crucial compo-
nent of implicit learning tasks like AGL and SRTT, but it is 
not necessarily a component of all procedural learning tasks. 
We would like to stress that depending on the exact admini-
stration of the task, procedural learning tasks may differ 
from implicit learning tasks in important ways. For instance, 
procedural learning tasks may be affected by explicit prob-
lem solving strategies, especially during the early stage of 
acquisition. Another potential difference is found in mirror 
reading and trail tracking tasks, where it is not clear whether 
subjects learn novel information about structured stimuli [see 
discussion in 4, 15]. 
  In the classical analysis of procedural learning (or skill 
learning), skill acquisition is viewed as gradually becoming 
less controlled and more automatized, corresponding to a 
transition from controlled explicit to automatic implicit proc-
essing [22]. It has been suggested that parallel explicit and 
implicit processes might be employed for this purpose [4, 13, 
23]. Further differences between procedural and implicit 
learning tasks are that acquisition and test phases are typi-
cally not separated in procedural learning tasks. However, 
the behavioral pattern and neural implementation revealed in 
neuropsychological studies are similar for procedural and 
implicit learning tasks [21, 24, 25], perhaps because of a 
shared implicit component. It is important to establish the 
robustness of neuropharmacological effects on the implicit 
learning system(s) through converging evidence from a 
range of tasks. Thus, we will include a discussion of two 
neuropharmacological models of automatization. We will 
also review studies that investigate procedural learning when 
the implicit component of the task seems relevant, although 
it is difficult to determine exactly how much explicit compo-
nents might contribute to behavioral and pharmacological 
effects. 
  In this review, we have occasionally chosen to include 
studies using probabilistic learning tasks. We only did so if 
the described task fulfills all criteria for implicit learning 
stated above [see also the discussion in 4, 14, 15] with the 
exception that we allow the information acquired to be 
somewhat less complex than in most implicit learning tasks. 
The simplest form of probabilistic learning is perhaps the 2-
choice probabilistic learning task. The task is to predict 
which of two events, A or B, will happen after a signal. 
Events A and B follow the signal in a random sequence, but 
with certain probabilities. For example, event A will occur 
75% of the times and B 25% of the times. The task can also 
include longer sequences that occur with certain probabilities 
and the probabilities might be changed within a session. 
When the probabilities are inverted or otherwise changed, so 
that B becomes the more common event, this is called rever-
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preted as an implicit learning task [26]. Since the knowledge 
acquired in the 2-choice probabilistic learning task and vari-
ants such as gambling tasks (where there are more choices), 
is simpler than in probabilistic sequence learning, contami-
nation by explicit strategies is a possibility. However, the 
implicit component in these tasks is probably still relevant 
enough for the purpose of this review. 
  Implicit memory is a concept that has been used in two 
ways in the literature, most commonly as a term exchange-
able with repetition priming. It is also used as a wider con-
cept that sometimes includes implicit learning [4]. In any 
case, in implicit memory tasks, acquisition is often tested on 
exemplars from the acquisition set, as in perceptual priming 
or repetition priming, while implicit learning more often use 
novel stimuli created according to the same principles as the 
acquisition or training set [4]. Generally, we will not review 
priming studies here, but we will include one implicit mem-
ory task [27] since it fulfills the criteria for implicit learning 
and does not use simple exemplar recognition but rather gen-
eration with the instruction to exclude the acquisition set. 
  The aim of this review is to provide an overview of re-
search in (healthy) human subjects - but animal data will be 
reported when it adds insight into the mechanism(s) demon-
strated in humans. In animal studies, tasks are sometimes 
conceptualized as procedural learning but there seems to be 
some confusion over what procedural or implicit learning 
should mean in animal models. However, there are recent 
examples of rule learning in cotton-top tamarins [28, 29], 
songbirds [30, 31], and rats [32] that are relevant for future 
neuropharmacological studies of implicit learning in animals. 
  Clinical data is considered where there is lack of other 
data and when this provides insights beyond clinical rele-
vance. We also note that related reviews have covered the 
neuropharmacology of cognition and memory in general 
[33], neuropharmacology of working memory [34], the role 
of basal ganglia, including its neuropharmacology, in habit 
formation [35-37], the role of neuropeptides, especially vaso-
pressin, in animal studies of learning and memory [38] and 
the role of dopamine in actions and habit formation [39]. 
But, there is yet no systematic review with a focus on the 
neuropharmacology of implicit learning. 
  In this review, one might sometimes get the impression 
that we are suggesting that there is a single effect or effect 
direction of a pharmacological agent acting on a transmitter 
system, for example. Generally, this should be understood as 
a (over-)simplification of the true, underlying complexity 
which is more closely related to for example plasma or tissue 
concentrations of the pharmacological agent, as well as its 
pharmacokinetics and pharmacodynamics. In this respect, 
studies reporting dose-response-curves are more informative 
than studies which only investigate a single dose level. How-
ever, the former type of study has, to a large extent, not yet 
been conducted in the context of implicit or procedural learn-
ing. The ideal would be to discuss investigations of moderate 
increases or decreases in neurotransmitter function, coupled 
to moderate increases or decreases in plasma concentration 
of agonistic or antagonistic agents, within a physiologically 
relevant range (as distinguished from a wider pharmacologi-
cal range). For the purpose of this review, we tentatively 
assume that the studies reviewed are more or less appropri-
ately designed from this point of view, as long as no conflict-
ing information is reported in the literature. However, it has 
to be kept in mind that full-range dose-response studies are 
generally lacking. 
2. A BRIEF OVERVIEW OF RELEVANT NEURO-
ANATOMY 
  Here we provide a very brief overview of the neuroanat-
omy and the clinical relevance of the four main neuromodu-
lators discussed in this review. The dopamine (DA) system is 
divided into four major pathways (Fig. 1). The mesolimbic 
and mesocortical system originate in the ventral tegmental 
area (VTA) and project to limbic (nucleus accumbens/ventral 
striatum) and prefrontal cortex, respectively. Over-activity in 
these systems is related to various psychological or psychiat-
ric symptoms, including euphoria, psychosis, and schizo-
phrenia. The nigrostriatal DA system originates in substantia 
nigra of the mesencephalon. The pathway projects primarily 
to the dorsal striatum, and under-activity is associated with 
Parkinson’s disease (the tubero-infudibular DA system is not 
considered here). 
  In addition to VTA and substantia nigra, the mono-
aminergic brainstem consists of the raphe nucleus and the 
locus coeruleus, from which the serotoninergic (Fig. 1) and 
the noradrenergic systems (Fig. 2) originate, respectively. 
The noradrenergic system projects to the cerebellum, hippo-
campus and neocortex while the serotonin system projects to 
all of these structures as well as the striatum. The nucleus 
basalis (of Meynert) in the ventral forebrain is the origin   
of cholinergic neurons projecting to cortex and limbic   
structures. The medial septal nuclei provide cholinergic   
projections to the cortex, limbic structures, and the hippo-
campus (Fig. 2). The third cholinergic origin is the ponto-
mesencephalo-tegmental complex (laterodorsal tegmental 
and pedunculo-pontine tegmental nuclei) which projects to 
the brainstem, thalamus and the basal forebrain. Cholinergic 
under-activity is associated with Alzheimer’s disease. In the 
context of this review, it is notable that neither the noradren-
ergic nor the cholinergic system projects directly to the   
striatum. 
  The most well-studied interactions between the systems 
briefly outlined are: (1) serotonin dependent dopamine re-
lease; (2) dopamine and serotonin affecting acetylcholine 
release in the basal forebrain; and (3) interaction between 
dopamine and acetylcholine in the striatum. A dopamine 1 
(D1) receptor activation depolarizes cholinergic interneurons 
and enhances acetylcholine release. In contrast, activation of 
dopamine 2 (D2) receptors on cholinergic interneurons in-
hibits striatal acetylcholine release, reviewed in [40]. There 
is also much evidence for serotonin agonists increasing ace-
tylcholine release in the basal forebrain [41]. Serotonin can 
also modulate dopamine function and dopamine release both 
positively and negatively (primarily by modulating dopa-
mine levels in cortex). But, there is also evidence that DA 
neurons in the VTA are under excitatory control by sero-
toninergic neurons in prefrontal regions, reviewed in [42]. 
Thus, there are several possibilities for complex interactions 
between these systems, which are yet to be described. Such 
interactions cannot be excluded as the actual cause of behav-370    Current Neuropharmacology, 2010, Vol. 8, No. 4  Uddén et al. 
ioral effects that we here interpret as findings supporting the 
involvement of a particular transmitter system in implicit or 
procedural learning. This is a difficulty that can only be re-
solved through the systematic study of multiple systems   













Fig. (1). Dopamine pathways are drawn in black and serotonin pathways in grey. The dopamine system has a substantial overlap with  















Fig. (2). Noradrenaline pathways are drawn in grey and acetylcholine (cholinergic) pathways in black. They project directly to hippocampus 
but not to striatum. More generally, these two systems are not projecting as specifically to fronto-striatal circuits as the dopamine and  
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3. RELATED MODELS APPLIED TO IMPLICIT 
LEARNING 
  We start with reviewing five computational models that 
focus on the basal ganglia and cover relevant aspects related 
to the neuropharmacology of implicit learning: (1) Doya’s 
computational model of reinforcement learning; (2) Berns 
and Sejnowskij’s model of sequence production; (3) Frank’s 
model of probabilistic learning and; (4) Ashby, Ennis and 
Spiering’s COVIS model of perceptual categorization; and 
(5) Ashby, Ennis and Spiering’s SPEED model of automatic-
ity in perceptual categorization [43-46].  
  Reinforcement learning is a computational framework 
concerned with how an agent ought to take actions in an en-
vironment in order to maximize its reward. The agent is de-
pendent on getting a variable reward signal in order to learn 
how to maximize its reward and in this sense, the learning is 
supervised. Implicit learning on the other hand typically does 
not include supervised feedback. Thus, we will now com-
ment on why we review Doya’s model for reinforcement 
learning [46] in the context of implicit learning. Petersson 
and colleagues [47, 48] described a non-supervised acquisi-
tion mechanism based on predictive learning that provides 
system internal feedback based on internal prediction. Thus, 
despite definitional differences between non-supervised im-
plicit learning and reinforcement learning, we think they 
might partly overlap in their mechanistic implementation. 
Common mechanisms might include computation of pre-
dicted outcomes and the presence of (internal) error signals. 
A control signal that determines the amount of exploration of 
unknown territory versus exploitation of already acquired 
knowledge is a part of the reinforcement learning framework 
that could also be related to implicit learning. Such a control 
signal would be relevant as an interface between the overall 
goals of the organism and the core learning mechanism in 
both implicit and reinforcement learning. From this point of 
view, early phases of implicit learning might for instance be 
characterized by exploration rather than exploitation (i.e. 
goal driven action execution). Common mechanisms would 
probably be implemented in the basal ganglia, a neuro-
anatomical focus for both implicit and reinforcement learn-
ing. 
  The functional roles of neuromodulators have been con-
ceptualized in terms of control parameters regulating learn-
ing mechanisms. The characteristics of such control parame-
ters were specified by Doya [46] for reinforcement learning, 
based on evidence related to the basal ganglia learning sys-
tem. Doya [46] proposed the following roles of the mono-
aminergic and cholinergic systems: (1) dopamine controls a 
global learning signal that encodes the discrepancy between 
predicted and received reward; (2) acetylcholine controls a 
learning parameter scaling this signal; (3) serotonin controls 
a discount factor, assigning exponentially less weight to re-
ward predictions further in the future; and (4) noradrenaline 
controls a noise term in the action choice that is supposed to 
balance exploration and exploitation. In the case of dopa-
mine, the model is uncontroversial and in line with the other 
models reviewed in this paper.  
  The perspective on serotonin is also uncontroversial and 
based on evidence that low levels of serotonin are associated 
with decreased behavioral inhibition and impulsiveness, for 
example prioritizing small immediate rewards before larger, 
delayed rewards (i.e., promoting “greediness”). In a recent 
review [49] this view was supported and serotonin was again 
considered as important for delay discounting and perhaps 
also for uncertainty discounting (meaning that less weight is 
assigned to uncertain predictions). The suggested role of 
noradrenalin in Doya’s model has been supported by primate 
perceptual data, for example visual discrimination [50]. 
However, it is an open question whether its role as a control-
ler of the balance between exploration and execution gener-
alizes to higher cognitive functions.  
  The reason given for modeling acetylcholine as control-
ling the learning rate (i.e., rate of acquisition) was that ace-
tylcholine (ACh) modulates long-term potentiation (LTP) in 
various learning tasks through muscarinic ACh receptors. 
However, LTP is also dependent on the AMPA and N-
methyl-D-aspartic acid (NMDA) receptors, and is modulated 
by dopamine, so this part of the model is probably too sim-
ple. From the perspective of this model, it can be predicted 
that implicit and other types of learning would be facilitated, 
at least in the acquisition phase, by moderate dopamine in-
creases (since a magnified learning signal could translate 
into improved acquisition). Somewhat higher than normal 
levels of acetylcholine during initial acquisition could facili-
tate fast learning, but it could also lead to an unstable oscilla-
tory solution to the acquisition problem. Low learning rates 
means proceeding accurately but very slowly across the error 
surface. Thus, for implicit learning over very long periods 
where high accuracy is crucial, low acetylcholine levels 
could be preferred. In any case, performance impairment is 
expected in case of dopaminergic or cholinergic dysfunction. 
  Lower levels of dopamine and acetylcholine after acqui-
sition might prolong the time window during which the ac-
quired knowledge is remembered. Too high levels, both dur-
ing the acquisition and the test phase, would mean that what 
is learnt might be overwritten and this would translate into 
instability and lower performance of the learning system. 
Implicit learning is predicted to improve by moderately high 
serotonin levels that optimize long-term prediction of reward 
and perhaps by somewhat lower than normal levels of 
noradrenalin (optimizing exploration), at least during acqui-
sition. 
  One suggestion in Doya’s model was that VTA DA in-
nervation of the prefrontal cortex mediates the selection of 
which task-dependent representation of states and actions 
(i.e., the input to the striatal reinforcement learning equa-
tions) should be acquired. For instance, there is always a 
choice at what level of detail an environmental object should 
be internally represented and the level of detail chosen might 
substantially affect the acquisition process. Thus, dopamine 
is not only signaling discrepancy between predicted reward 
and actual reward, but it may also be a key player in select-
ing the input on which predictions are computed. Ellis & 
Nathan [34] suggested that a mechanism for this function 
could for instance be dopamine mediated control of working 
memory [for a review of the pharmacology of working 
memory see 34]. This was based on evidence that sustained 
prefrontal activity during working memory tasks is depend-372    Current Neuropharmacology, 2010, Vol. 8, No. 4  Uddén et al. 
ent on the amount and type of reward associated with the 
memorized items. Studies using dual task paradigms have 
showed that working memory is important for implicit learn-
ing of hierarchical relations, such as learning the positional 
dependencies between elements in a sequence in AGL [for a 
review see 4]. Two studies have demonstrated a correlation 
between AGL classification performance and working mem-
ory in schizophrenic patients [51] and healthy volunteers 
[52]. 
  Berns and Sejnowskij [44] modeled the effect of dopa-
mine as the difference between predicted and actual reward 
similarly to Doya [46]. In their model of sequence produc-
tion, sequences are generated by the basal ganglia. A short 
term memory loop of inhibitory recurrent connections be-
tween globus pallidus externa and the subthalamic nucleus 
plays a central role in this model. This memory device, pro-
posed to operate on a timescale of 10 to 100 ms, can store 
sequences of states projected to globus pallidus externa from 
striatum. Action selection is made through a comparison of 
the input to globus pallidus interna by lateral connections 
from globus pallidus externa and direct projections from 
striatum, in this model. The recurrent circuit between globus 
pallidus externa and the subthalamic nucleus was also   
considered in Doya’s model [46], where it computed the 
global DA learning signal. Berns and Sejnowskij [44] further  
suggested that dopaminergic neurons in substantia nigra and 
ventral tegmental area fire as a consequence of both external 
and internal reward. The tacit assumption here is that a tonic 
level of dopamine activity is required to maintain synaptic 
efficacy and therefore allow the learning signal to be either 
positive or negative [this also holds for 46]. It was also sug-
gested that dopamine modulates the long-term potentia-
tion/long-term depression (LTP/LTD) of both striatal and 
pallidal synapses by altering the concentration of intracellu-
lar calcium. 
  Franks’s model [45] describes the role of dopamine in the 
basal ganglia and prefrontal cortex in probabilistic learning; 
for example, the weather prediction task [53] and probabilis-
tic reversal learning [45]. These tasks were chosen for the 
purpose of modeling behavior of medicated and non-
medicated Parkinson patients, since these patients seem to be 
impaired on tasks that rely on trial-and-error learning. The 
author emphasized that a large dynamic range in dopamine 
release is critical for this kind of basal ganglia dependent 
learning. Unfortunately, no direct comparison was made 
between the role of dopamine in trial-and-error dependent 
and independent implicit learning in the model. Bearing 
Frank’s model in mind, it is of particular interest for the cur-
rent review to establish whether dopamine has been impli-
cated in implicit learning that does not rely on trial-and-error 
learning (i.e. tasks not using feedback). Frank reviewed em-
pirical evidence that positive and negative feedback has op-
posite effects on the dopamine release, in line with Doya 
[46] and Berns & Sejnowski [44]. As in Berns & Sejnowski 
[44], it was suggested that the convergence of the indirect 
and direct pathway in the globus pallidus interna indicates 
that a competitive mechanism might control the output to the 
thalamus. 
  Ashby and colleagues’ COVIS model and its extension 
SPEED are neurobiological models centered on category 
learning. In their sense, category learning is based on infor-
mation integration as opposed to explicit rule application. 
This makes the models interesting from the point of view of 
implicit learning [43]. The model assumes that an implicit 
basal ganglia system uses procedural learning mechanisms to 
acquire categories. It proposes a cellular mechanism for this, 
in the form of dopamine mediated synaptic strengthening, 
connecting cortical axons with medium spiny dendrites in 
the striatum, with a focus in the body of the caudate nucleus. 
As in Berns & Sejnowski [44], Frank [45], and Doya [46] 
dopamine was regarded as a learning signal for unexpected 
reward or omission of expected reward in both striatum and 
the prefrontal cortex. SPEED adds a neural mechanism for 
automaticity to COVIS. This mechanism strengthens cortico-
cortical pathways through Hebbian learning. Ashby et al. 
argued that this mechanism is relatively independent of do-
pamine, based on the fact that dopamine signals in prefrontal 
cortex have poor temporal resolution. This is in line with the 
prediction we have outlined above, building on Doya’s 
model [46]: an intact dopamine system is important in the 
early phase of learning, but perhaps less important later in 
the acquisition process, where e.g. skills become more auto-
matic. It is also in line with the reasoning in the review of 
Wickens et al. [39] where pharmacological disturbances in 
early stages of learning are thought to impair performance on 
habit learning tasks generally by disrupting the throughput of 
information across task-relevant cortico-striatal synapses. 
Such impaired performance was shown for acquired appeti-
tive responses in rats [39]. 
  Altogether these models converge in their view on striatal 
dopamine as a global learning signal playing an important 
role in reinforcement, sequence, category, and probabilistic 
learning. Prefrontal dopamine was suggested to be involved 
in the selection of acquisition of internal representations of 
the environment, which form the input to the reinforcement 
learning processes in the striatum [46]. It was believed that 
dopamine determines the strength of cortico-striatal syn-
apses, but that it is of relatively minor importance for cor-
tico-cortical pathways. These cortico-striatal pathways are 
suggested to play a role in the development of automaticity 
in a gradual process. Automatic processing will eventually 
rely on cortico-cortical pathways only. This suggestion is 
similar to how memories are thought to iteratively consoli-
date in cortical areas after first having been dependent on 
hippocampus as a hub binding together distributed storage 
sites in neocortex [23, 43, 54, 55]. The time course sug-
gested, including an initial important role of dopamine which 
later fades out, can be interpreted as consistent with the time 
course in Doya’s model [46]. Dopamine might be particu-
larly important for implicit learning involving trial-and-error 
with feedback [45]. To sum up the model’s view on the other 
neuromodulator systems, acetylcholine is seen as controlling 
the balance between memory vs. renewal; serotonin is con-
trolling the balance between short and long-term prediction 
of reward; and noradrenaline controls the balance between 
exploration and exploitation. 
4. DOPAMINE 
  Nagy and colleagues [56] measured plasma levels of ho-
movanillic acid (HVA) as a marker of dopamine metabolism 
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simple sequence learning task with feedback. This task was 
constructed so that errors are made if subjects respond in a 
stimulus-response fashion, without having acquired the exact 
positions of the elements in relatively short sequences (maxi-
mum 4 items long). In a test phase without feedback, 
performance was impaired in amnesic patients, but not in 
Parkinson’s patients, while the opposite pattern was seen in 
the training phase [56]. This evidence suggests that there 
might be an implicit learning component in the training 
phase that is related to dopamine function, since the nigros-
triatal dopamine pathway is malfunctioning in Parkinson’s 
disease. Nagy and colleagues [56] reported that increased 
dopamine metabolism (prior to acquisition) was negatively 
correlated with the number of errors. No significant correla-
tions were found between plasma indicators of serotonin and 
noradrenaline metabolism and the number of errors. Interest-
ingly, there was no correlation between dopamine metabo-
lism and error rates in the later test phase, where the subject 
is supposed to apply the acquired sequence knowledge. This 
supports the hypothesis that dopamine is more relevant in an 
early learning phase, a possibility we have discussed in the 
section on models related to implicit learning above. An al-
ternative explanation is that performance is only dopamine 
dependent during feedback, which was only present during 
the training phase. 
  A number of studies that have investigated how learning 
is affected by antipsychotic treatment of schizophrenia are 
interesting also from a non-clinical perspective, since they 
point to an involvement of the dopamine system in implicit 
learning independent of the disease [for a recent review of 
implicit sequence learning in schizophrenia which also dis-
cusses clinical aspects, see 57]. In a study that compared the 
new antipsychotic olanzapine with the traditional bench-
mark drug haloperidol and equivalents, it was concluded that 
implicit learning in the serial reaction time task [15, 18] was 
not impaired in non-treated schizophrenia (although this was 
not directly tested). Classical neuroleptics like haloperidol 
did impair implicit learning in the SRTT, while this was not 
the case for olanzapine. No detrimental effects were found in 
schizophrenic individuals under treatment with olanzapine 
compared to untreated healthy controls. This between drug 
effect was specific for implicit learning in the serial reaction 
time task (measured as the relative improvement in reaction 
times over blocks) since no such effect could be demon-
strated in an explicit spatial memory task [58]. 
  The pharmacological profile of olanzapine is complex 
and involves different actions on the DA, serotonin (5-HT) 
and cholinergic systems. However, some aspects of the com-
pounds complex effect have been studied. In schizophrenics 
treated with either olanzapine or haloperidol, dose dependent 
effects of D1 and D2 availability in the striatum measured by 
SPECT has been demonstrated [59]. Haloperidol is a rela-
tively pure D2-antagonist with higher affinity for the D2-
receptor than olanzapine. A tracking task was performed 
directly after injection of a radioligand with high D2-
specificity. Performance correlated significantly with D2-
binding in the striatum in a haloperiodal treatment group, but 
not in a olanzapine group. Interestingly, and consistent with 
the data reported above, this study [59] also reports impaired 
procedural learning under haloperidol treatment. The per-
formance of patients treated with olanzapine was on the 
other hand not significantly different from that of unmedi-
cated healthy controls. These findings are in line with find-
ings by Purdon et al. [60], where haloperidol caused im-
paired procedural learning in the Tower of Toronto task, a 
puzzle of intermediate difficulty compared to the Tower of 
London and Tower of Hanoi.  
  In all of these Tower tasks, there are disks stacked in 
ascending order of size on one rod, the smallest disk at the 
top. The objective of the task is to move the entire stack of 
disks to one of two other rods, moving one disk at a time and 
without placing a bigger disk on top of a smaller disk. In 
simple versions, the solution with the least number of moves 
can be found by problem solving, at least in healthy subjects. 
In harder versions, the procedural learning component be-
comes more prominent and this goes along with an increased 
the number of moves that varies depending on procedural 
learning proficiency. The Toronto version of the Tower tasks 
was designed to maximize the procedural learning compo-
nent, in the sense that individual moves should not be memo-
rized and subjects should be unable to consciously recall a 
successful sequence [21]. The impaired performance on the 
Tower of Toronto task in schizophrenic patients was found 
after six months of medication [60]. This result suggest that 
D2 blockade has a general negative impact on this proce-
dural learning task, but that this impact is circumvented by 
other aspects of the newer drugs like olanzapine. The authors 
suggest that either the anticholinergic properties of olanzap-
ine or the increased 5-HT2 receptor blockade might compen-
sate for the D2 receptor blockade. A stratified analysis 
showed trends for better performance by patients who had 
gotten additional anticholinergic treatment compared to 
those who had not. The fact that these effects are found in 
striatum [59] and perhaps the dorsal striatum specifically is 
interesting from an implicit learning perspective, since stria-
tum is one of the structures most consistently activated by 
implicit learning tasks [2]. Altogether, these three studies 
provide some evidence for dopamine involvement in implicit 
learning independent of trial-by-trial feedback, since no 
feedback was provided [58-60]. 
  Kumari and colleagues [61] studied behavioral perform-
ance in healthy subjects in a procedural learning task where 
subjects had to touch one of four locations of a target that 
was moving with random or predictable movements, with no 
training prior to drug administration. This task resembles 
versions of the serial reaction time task [15, 18]. Haloperidol 
and d-amphetamine (a dopamine agonist) had opposite ef-
fects. D-amphetamine shortened the response times of pre-
dictable movements compared to random movements, 
whereas in the haloperidol group, they were stable or even 
increased. These results are consistent with Doya’s model 
(i.e., the effects go in the predicted direction). However, the 
interpretability of the d-amphetamine part of the results is 
somewhat weakened by the fact that d-amphetamine acts on 
many systems and may speed up responses in general. This 
criticism is mitigated by the fact that the effect of faster   
response times was measured as the difference between   
the reoccurring sequence and the random sequences and a 
general speed up would mean that this difference would have 
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  Two studies in rats used procedural learning paradigms 
to assess effects of D1 and D2 receptor antagonists as well as 
long term effects of striatal dopamine depletion on sequential 
motor learning. If the dopamine depletion exceeded 40%, 
sequential motor learning was impaired up to six weeks after 
the depletion treatment [62]. Injection of both D1 and D2 
receptor antagonists had detrimental effects on a task sup-
posed to correspond to the human serial reaction time task. 
The rats had been trained on this task for 40 days prior to the 
4 day treatment period. Response rate and accuracy was 
lower and reaction times were longer after excessive dopa-
mine depletion. In a between subjects comparison, it was 
found that reaction times were specifically prolonged in rela-
tion to manipulation of the D2 receptor [63]. A possible ex-
planation for D2 specificity is that D2 receptors inhibit ace-
tylcholine release, while D1 receptors have the opposite ef-
fect. Such complex interaction between these two systems 
calls for further research. A possible D2 specificity for do-
paminergic modulation of implicit learning should also be 
further investigated and we note that the results on haloperi-
dol above are consistent with the D2 specificity hypothesis. 
  Two studies reported negative results. Czernecki and 
colleagues [64] concluded that L-dopa (a precursor to dopa-
mine) treatment in patients with Parkinson’s disease did not 
ameliorate impaired implicit learning in Parkinson patients. 
The authors argued that the gambling task used in the study 
is an implicit learning task since both patients and controls 
showed progressive learning in absence of explicit aware-
ness. The task was to distinguishing which two decks of 
cards out of four were advantageous in the long run (i.e., 
producing larger monetary reward, later) and which two 
were disadvantageous (smaller monetary reward, sooner). 
The explicit component was assessed after the task and 50% 
of the controls and 13% of the patients became aware of the 
distinction between the decks. This task has clear similarities 
to the classical 2-choice probabilistic learning task in the 
sense that feedback on the subject’s decisions is provided. 
The authors wrote “This kind of implicit learning would re-
quire processes of long-term consolidation which are proba-
bly poorly sensitive to the short-term fluctuations of dopa-
minergic therapy” [64]. 
  However, when considering the data presented in this 
study, it looks like the L-dopa administration had a detrimen-
tal effect on learning in the gambling task. In a session with 
5 blocks, controls and patients without treatment showed 
highly significant increases in performance, while patients 
with treatment showed no significant improvement. This 
pattern of results was not present in a second session, admin-
istered the next day. The patients who were non-treated ear-
lier received L-dopa and the treated patients received no L-
dopa. Both patient groups showed stable performance over 
blocks, in contrast to the controls who were still improving 
significantly. There are several possible reasons for the ab-
sence of learning in the patient groups in the second session 
(for instance a motivational drop), but the data is also consis-
tent with the interpretation that L-dopa treatment impairs 
further learning in this study. 
  Witt and colleagues [25] compared four patient groups 
with controls in an artificial grammar learning task. The pur-
pose was to test the causal role of the basal ganglia in this 
task through measuring implicit learning in advanced and 
non-advanced patients. The advanced patients were meas-
ured both in a medicated stage (varying treatments but all 
with positive effects of L-dopa treatment) and after at least 
12 h of withdrawal from all drugs. The role of cerebellum 
was also investigated on patients with cerebellar degenera-
tion. No significant effects were found between patient 
groups and controls or between treatments. There was a ten-
dency for Parkinson patients being more affected the more 
advanced the disease was and thus the possibility that the 
absence of results is potentially an effect of limited statistical 
sensitivity is important to note [25]. 
  Altogether, these results suggest that intact dopaminergic 
function is necessary for normal performance on implicit 
learning tasks, most clearly in the acquisition phase, as pre-
dicted [39, 43-46]. There is evidence for improved learning 
when moderate levels of dopamine agonistic agents are ad-
ministered. There is even more evidence for impaired learn-
ing by antagonistic agents. The effects show anatomical con-
vergence in the striatum, most prominently the dorsal part 
[58-61]. Taken together, these results support the hypothesis 
that dopamine determines the strength of cortico-striatal syn-
apses during the development of automaticity. It has been 
demonstrated that individual differences in the state of do-
pamine metabolism during learning affect the acquisition. 
There is also support for a role of the dopamine system in 
tasks that do not rely on trial-and-error feedback learning 
[58-61]. For a review on all dopamine results, see Fig. (3), 
Table 1. 
5. SEROTONIN 
  Citalopram, a selective serotonin reuptake inhibitor 
(SSRI), increases immediate sensitivity to misleading feed-
back. Chamberlain and colleagues [65] investigated citalo-
pram in the context of a two alternative forced choice prob-
abilistic learning task. There was a 8:2 ratio of posi-
tive:negative feedback for the correct choice and the con-
verse for the incorrect choice. Without prior training on the 
task, performance was impaired after oral intake of a single 
dose of the selective serotonin reuptake inhibitor (SSRI) 
compared to placebo controls, both in terms of response 
times and accuracy. This could be due to either sub- or su-
pra-optimal levels of serotonin, both possible consequences 
of initial SSRI administration. SSRI was used to increase 
serotonin levels but initially it can have the opposite effect. 
Whether the observed effect was due to too low or too high 
serotonin levels is impossible to say, but it seems clear that 
the placebo controls’ levels are closer to optimal. 
  Cruz-Morales and colleagues [71] exposed rats to re-
straint and 24 h later these were exposed to an elevated maze 
stressor which had open and closed arms. The authors sug-
gested that procedural learning in this task depends on sero-
tonergic activity in the striatum [71]. We note that increased 
avoidance latencies in elevated mazes has also been ob-
served after 3,4-methylenedioxymethamphetamine (MDMA) 
exposure, which among other effects causes serotonin deple-
tion. The increased avoidance latencies were measured three 
months after 48 h MDMA exposure. The training had begun 
directly after the exposure [72]. In a similar study, the same 
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after a single injection of MDMA [73]. However, in both 
cases, the effects were interpreted as resulting from increased 
anxiety and the procedural learning perspective was not 
taken. These three rat studies suggest a role of serotonin in 
avoidance learning, which is the main learning component in 
the elevated maze task (see Fig. (4), Table 2). Avoidance 
learning in the elevated maze task has been interpreted as a 
procedural learning paradigm in at least one study [71], but 
its relevance for implicit learning is still controversial [for a 
discussion of the relevance of maze task for implicit learn-
















Fig. (3). The figure presents an overview of the results on healthy volunteers and patients. From above, the arrows correspond to a manipula-
tion with moderately increased neurotransmitter function. Arrows from below represent moderate decreases. At the arrow head, the direction 
of the performance change is indicated, with a plus for a performance increase and a minus for impaired performance. In addition, a dashed 
line indicates that there was a performance increase and a solid line that there was a performance decrease. 
 
Table 1.  Review of Human Data on the Neuropharmacology on Implicit Learning Tasks 
Agent  Study  Modulatory Direction  Sequence Learning  Probabilistic Learning  Procedural Learning 
Dopamine [56,  61]     -  - 
Dopamine [64]   -  - 
Dopamine  [25, 56, 58, 61]     -  - 
Dopamine [59,  60]   - -   
Serotonin [65-67]   -  - 
Acetylcholine [68]   - -   
GABA [27]/[69] /  / -  - 
GABA [70]   -  - 
Table 1. The table summarizes the reviewed articles by transmitter system, sorted on a moderately induced increase () or decrease () in neurotransmitter function. The most rele-
vant findings are those that modify implicit learning of sequences, producing performance enhancements () or interferences (). We have also reviewed studies of probabilistic 
learning (most relevant in connection to serotonin) and procedural learning of complex tasks (puzzles or tracking tasks). 376    Current Neuropharmacology, 2010, Vol. 8, No. 4  Uddén et al. 
  Depletion of the serotonin precursor tryptophan impaired 
response speed in probabilistic reversal learning in healthy 
volunteers [67]. The task used was a classical probabilistic 
learning task with feedback, repeated in two sessions after 
intake of an amino acid mixture with or without tryptophan. 
The ratio 8:2 of positive:negative feedback given in the trial 
by trial feedback was inverted once during the session. Tryp-
tophan depletion, a well-established method for reducing 
serotonin levels in the brain, increased response times, but 
only during the first session when the task was new to the 
subjects. This is consistent with the predictions from Doya’s 
model, where intact serotonin was predicted to affect implicit 
learning early more than late in the process. In an almost 
identical design, it was shown that probabilistic reversal 
learning during tryptophan depletion elicits a task related 
increase in the blood oxygen level dependent (BOLD) re-
sponse (functional magnetic resonance imaging, FMRI) of 
the dorsomedial prefrontal cortex. A marginally significant 
trend for increased response latencies related to the lower 
serotonin levels was also found [66]. Moreover, the dor-
somedial prefrontal cortex has been reported in FMRI stud-
ies of implicit artificial grammar learning without perform-
ance feedback [5, 8] as well as explicit artificial grammar 
learning with performance feedback [74-77]. These are some 
indications of a relationship between the serotonin system, 
the dorsomedial prefrontal cortex and implicit learning with 
and possibly without feedback, but further research is needed 
on this topic. 
  Taken together, these results provide some evidence for a 
serotonergic involvement in procedural learning, in particu-
lar in probabilistic learning tasks, in line with the predictions 
of Cardinal [49] and Doya [46] (see Fig. (3), Table 1). How-
ever, a serotonergic involvement in a classical human im-
plicit learning task like SRTT or AGL with and without 
feedback remains to be demonstrated. 
6. NORADRENALINE 
  There are yet no positive results showing a role for 
noradrenaline in implicit learning. Chamberlain et al. [65] 
found effects of serotonin on probabilistic learning but did 
not find any significant changes on the same task after intake 
of the selective noradrenaline reuptake inhibitor atomoxet-
ine. In addition, reboxetine, another selective noradrenaline 
reuptake inhibitor, showed no effect on finger sequence 
learning [80]. In a study that used clonidine, which among 
other things reduce the noradrenaline turnover, no effect was 
observed on a procedural motor learning task described be-
low [68]. Altogether, the absence of a relation between 
noradrenaline and implicit or procedural learning suggests 
that if such a relation exists, it is not prominent compared to 
other neurotransmitters, like dopamine for example. 
7. ACETYLCHOLINE 
  Frith and colleagues [68] found an effect of the acetyl-
choline antagonist scopolamine in a procedural motor learn-









Fig. (4). The reviewed rat data is summarized according to impaired performance in three varyingly precise categories of tasks: (1) an ani-
mal/rat version of the serial reaction time task; (2) avoidance learning; (3) sequential motor learning in general.  
 
Table 2.  Review of Animal Data on the Neuropharmacology on Implicit Learning Tasks 
Agent  Study  Modulatory Direction  Serial Reaction Time Task  Avoidence Learning   Sequential Motor Learning 
Dopamine [62]  /[63]  /  -/ -  /- 
Serotonin [71-73]   -   - 
Noradrenaline [78,  79]   -  -   
Table 2. The table summarizes the reviewed articles on rats by transmitter system. In all of these articles, a moderate decrease () in neurotransmitter function was induced. The most 
relevant findings for implicit learning are those that modify the serial reaction time task or other sequential motor learning tasks. All studies produced interferences with task per-
formance (). We have also included studies of avoidance learning (most relevant in connection to serotonin). Those are standing in the avoidance learning column. The Neuropharmacology of Implicit Learning  Current Neuropharmacology, 2010, Vol. 8, No. 4    377 
mirror reversed manner to track a slowly moving target. Af-
ter brief training on the task, subjects had intravenous infu-
sion of scopolamine and about half an hour later, the profi-
ciency in this task increased significantly. The comparison 
was made between the scopolamine group and clonidine or 
placebo groups. Comparing explicit and implicit processing, 
Nissen and colleagues [81] found effects of scopolamine on 
explicit but not implicit motor learning, subsequently repli-
cated by Bishop et al. [82]. This type of experimental design 
only provides a simple dissociation and leaves open whether 
the assessment of implicit processing was sensitive enough 
to detect behavioral changes or not.  
  Wenk and colleagues [79] found impaired choice accu-
racy in rats after lesions to the basal forebrain cholinergic 
system and the raphe nucleus, but not the locus coeruleus, in 
the probe phase of a T-maze task after at least four days of 
acquisition prior to operation. However, these results involve 
a spatial dimension that might be affected rather than the 
procedural learning component. Roloff et al. [83] demon-
strated a dissociation between these two components and 
they showed that both the spatial and the procedural learning 
component are affected by muscarinic acetylcholine receptor 
signaling in a series of four experiments. Vanderwolf [78] 
found impaired acquisition in a shock avoidance test after 
administration of scopolamine before acquisition and on 
retention, compared to another group of placebo treated rats. 
In a swim-to-platform test scopolamine only impaired acqui-
sition but not retention [78]. The relation between these rat 
tasks and implicit learning in humans is not straight forward 
to interpret [19] but at least some authors think that the role 
of acetylcholine in procedural learning in rats is uncontro-
versial and well-established [83]. In summary, there is not 
enough evidence to support a role for the cholinergic system 
in implicit learning generally, although there is evidence for 
impaired procedural learning in rats and some mixed results 
in humans. 
8. GABA AND BENZODIAZEPINES 
  In an interesting placebo controlled study the MTL 
memory system, including the hippocampus, was deactivated 
by using a GABA-A receptor agonist (midazolam; GABA-A 
receptors being densely expressed in the hippocampus). This 
resulted in improved implicit transitive inference, defined as 
the ability to infer transitive relations. A simple example of 
such a relation is the following: from A > B and B > C, it 
follows that A > C. The transitive relations used in the study 
were more complex. Interestingly, an explicit name recall 
task was impaired after the same treatment [69].  
  However, Greene [84] argued that there was no convinc-
ing evidence that the hippocampal inactivation caused the 
behavioral findings in [69]. We agree that other causes can-
not be excluded although the hippocampal inactivation ac-
count is certainly consistent with other experimental evi-
dence. In a reply to Greene, Frank et al. [85] emphasized that 
there is substantial evidence for inactivation of hippocampus 
after intake of midazolam, while there is no evidence for 
deactivation of for example striatum under the same condi-
tions. Frank et al. [69] interpret their results as at least partly 
resulting from a shifting balance in a competitive relation 
between striatum and hippocampus. Such a competitive rela-
tion is supported in a recent study of implicit learning using 
the artificial grammar learning task. The study shows medial 
temporal lobe deactivations during artificial syntactic proc-
essing [12]. 
  Cooperative interactions between the basal ganglia and 
the medial temporal lobe have also been reported [86]. How-
ever, other neocortical causes of the behavioral effects can-
not be ruled out. We also note that a dissociation of memory 
performance and the sedative effects of midazolam have 
been replicated using concentrations of midazolam which 
caused severe amnesic effects and equi-sedative doses of the 
drug fentanyl. Fentanyl produced no effect on recognition of 
words from a wordlist and verbal recall of pictures [87]. 
Thus we conclude that the results of Frank et al. [69] provide 
some evidence of a role for the GABA-A receptor in an im-
plicit learning task. In this task subjects were instructed to 
base their decisions on their “gut feeling” and subjects gen-
eralized by applying previously acquired regularities to novel 
items. These are two important features of how the AGL task 
is commonly administered and they make this version of the 
implicit transitive inference task more interesting from an 
implicit learning perspective. The results might be due to a 
deactivation of hippocampus subsequent to midazolam in-
take. Alternative explanations are: (1) increased activation of 
the indirect pathway of the striatum, which has been shown 
after administration of midazolam, measured with two dif-
ferent neuropeptide markers [88, 89] (2) increased dopamine 
and dopamine metabolite levels as well as turnover rate in 
the striatum, which has been demonstrated after administra-
tion of a benzodiazepine [90] and (3) neocortical effects. 
  However, modulation of GABA receptors with benzodi-
azepines has also resulted in opposite effects. Placebo con-
trolled pentobarbital impaired procedural learning in a se-
quence learning task resembling the serial reaction time task 
[70]. Lorazepam induced impairments in both explicit and 
implicit learning in a word stem completion task where im-
plicit learning was defined as the rate of erroneously in-
cluded word stems from a word list [27]. This is an example 
of an implicit memory or priming task, which might or might 
not be related to implicit learning. Altogether, these findings 
suggest that the GABA-A receptor system is involved in 
implicit or procedural learning. Some concerns about speci-
ficity remain since benzodiazepines also induce altered states 
of wakefulness and attention. Since neither plasma levels or 
dose-response curves were reported, it is possible that the 
opposite direction of the results (see Fig (3), Table 1) might 
be a dose effect, for instance too high GABA levels in the 
last two studies above (although no specific details in the 
administration or dose of the drug support this suggestion). 
9. AMPAKINES  
  Ampakines have theoretically interesting properties and 
effects, including induction of enhanced plasticity and re-
gional specificity of induction as well as amplification of 
LTP. We review this class of drugs although the potential 
effects of ampakines on implicit learning have not yet been 
investigated. Ampakines are allosteric modulators of the 
AMPA receptor that partially interrupt desensitization and 
deactivation of the excitatory postsynaptic current, producing 
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terms of amplitude and duration of the excitatory postsynap-
tic current. The NMDA glutamate receptors that trigger LTP 
are both voltage-gated and ligand-gated. Mg
2+ is blocking 
the ion channel. Co-localized AMPA receptors can cause a 
rapid depolarization that removes the magnesium ion and 
lets calcium flow into the cell. Because the NMDA channels 
are relatively slow to open, this NMDA dependency on 
AMPA postsynaptic receptor-mediated currents will depend 
on both the duration and the amplitude of the currents [91]. 
Thus, ampakines can have large effects on these NMDA 
channels. In terms of LTP, the induction threshold is lowered 
and the magnitude of the LTP increases [92]. An additional, 
secondary effect is increased production of brain derived 
neurotrophic factor (BDNF), in turn enhancing plasticity 
[92]. The mechanism of ampakines is neither agonistic nor 
antagonistic, but a dynamic modulatory effect on stimulus 
driven, endogenously produced, excitatory transmitter re-
lease. These properties might be especially suited for im-
proving implicit learning. Different positive modulators (po-
tentiators) of AMPA receptors have been developed. The 
ampakine CX516 affected deactivation selectively, while 
benzothiazide and cyclothiazide affected desensitization   
selectively, and CX554 affected both [for reviews see 92-
94]. However, there are no studies that report administration 
of the later two types in humans. 
  CX516 has been tested in healthy young adults at fairly 
high doses [95]. In a placebo-controlled study, Ingvar and 
colleagues [95] found improved performance on a spatial 
maze task and odor recognition, pictorial associations and 
another simple association task after ampakine administra-
tion. All these tasks are dependent on long-term memory 
processes in the different (spatial, odor, visual) domains. The 
design was a within subjects design were the test battery was 
repeatedly administered for five test days, two after 300 mg 
CX516 ampakine administration and three after placebo. In 
another study, healthy 50-65 year old subjects showed im-
proved recall of syllables [96]. Goff and colleagues [97] 
tested 19 schizophrenic patients and found therapeutic ef-
fects of an increasing dose of at least 300 mg and maximally 
1200 mg CX516 a day, during four weeks. Improvements of 
attention and memory were seen, measured with test such as 
Wisconsin card sorting test, letter-number span, verbal learn-
ing test, fluency tests and trail making tests. However, these 
results were not reproduced in a larger sample (n=105) 
where patients were given a 300 mg dose a day [98]. 
  CX717 is another ampakine which have been tested at 
high dosage in humans during electroencephalography 
(EEG) assessment. Modification of EEG activity during 
sleep in all bands except the theta band was demonstrated 
[99]. The authors interpreted the pattern of changes in   
oscillatory activity as increased arousal [99]. However, in a 
follow-up study, similar dosages were not found to affect 
behavior by night shift workers performing a delayed match-
to-sample task, a vigilance psychomotor task, and a wake-
fulness test. This test was done during four nights where a  
different dose of CX717 was administered each day [100]. 
  Interestingly, there was a dose-dependent effect of the 
same ampakine on a delayed match-to-sample task in rhesus 
monkeys. This was true for both normal and sleep deprived 
monkeys in a within subjects design [101]. The delayed 
match-to-sample task is a working memory task where a 
choice between two items has to be made, so that the chosen 
item matches some feature of a target item that has been kept 
in mind during a delay period. This task has been extensively 
used in animals and for cross-species comparisons [102]. 
The enhancement of performance in the delayed match-to-
sample task due to ampakine administration was specific to 
the brain regions involved in the task as measured by glucose 
consumption. This was assessed with PET [101]. 
  Faramptor is an ampakine developed for improvement of 
negative symptoms and cognitive function in schizophrenics 
[103]. It is supposedly more potent than CX516 [103]. These 
authors tested healthy elderly volunteers and found effects of 
a single administration of 500 mg faramptor on accuracy of 
incidental learning in symbol recall and recognition. There 
were no effects on word list recall. Recall here refers to a 
memory task where the remembered item has to be produced 
(e.g. in speech, writing or drawing). Indication of which 
items are the remembered ones is sufficient in recognition 
tests. 
  In summary, ampakines have been tested in humans but 
mainly for clinical purposes and mainly for declarative 
memory and working memory. These studies provide evi-
dence that ampakines can improve memory and learning in 
human subjects. In addition, there are theoretically promising 
properties of ampakines, such as regional specificity of in-
duction, enhanced plasticity, and amplification of LTP. Al-
together, this renders ampakines a potentially interesting 
class of drugs to explore in relation to implicit learning. 
10. CONCLUSIONS 
  First a note of caution with respect to claims of dissocia-
tions between the neuropharmacology of implicit and ex-
plicit learning. Here, one must be careful not to over-
interpret simple dissociations such as when explicit but not 
implicit learning is effected, for example by scopolamine 
[81, 82], since null effects might be related to low sensitivity 
in the experimental task chosen to probe a given learning 
system. Negative results might be interpretable, but this re-
quires high sensitivity in the experimental task(s) in combi-
nation with receptor specific pharmacological agents. Pref-
erably, well-characterized dose-response curves should be 
provided. Moreover, if additional measures of intervention 
effects, for example functional neuroimaging data, are ac-
quired in addition to behavioral results, conclusions concern-
ing regional specificity are easier to substantiate. 
  Concerning the neuropharmacology of implicit learning 
there are still large gaps in the published literature. However, 
we can already draw some tentative conclusions (for an 
overview of the reviewed results see Figure (3), Table 1 for 
human results and Fig. (4), Table 2 for animal results). It 
seems well-established that dopamine agonists/antagonists 
can modulate implicit and procedural learning in directions 
predicted by computational models of the basal ganglia. The 
effects of dopamine are most prominent during the early 
phases of acquisition and localized to the striatum, possibly 
the dorsal striatum [58-61]. Effects of dopamine on behavior 
have been observed also when there is no feedback provided 
[58-61]. There is some evidence for an involvement of sero-The Neuropharmacology of Implicit Learning  Current Neuropharmacology, 2010, Vol. 8, No. 4    379 
tonin on probabilistic learning in humans and avoidance 
learning in rats. Generally, the impact of serotonin on im-
plicit learning is probably greater than that of acetylcholine. 
Acetylcholine has been demonstrated to have some effects 
on implicit learning, while the demonstrated effects of 
noradrenaline are scarce. The predictions from the reviewed 
computational models hold for both dopamine [39, 43-46] 
and serotonin [46, 49]. However, the evidence for noradrena-
line and acetylcholine in implicit or procedural learning   
is too scant to draw any conclusions. One reason, why this 
might be the case, is the fact that unlike the dopamine   
and serotonin system, neither of these systems project   
directly to the striatum. The reviewed literature also suggests 
that the GABAergic system might be involved in implicit 
learning. 
  In general, further detailed investigations of neurophar-
macological mechanisms by means of dose-response curves 
is an important next step that could support more firm con-
clusions, given that some of the present findings are mixed 
with respect to the direction of behavioral effects (i.e. 
whether performance enhancements or impairments are 
seen). Finally, ampakines are allosteric modulators of the 
AMPA receptors. Performance enhancements after ampakine 
administration has been demonstrated in a spatial maze task, 
associative memory and other memory tasks. This makes 
ampakines potentially interesting to investigate with respect 
to procedural and implicit learning. 
ABBREVIATIONS 
DA   =  Dopamine 
5-HT   =  Serotonin 
ACh =  Acetylcholine 
GABA = -aminobutyric acid 
NMDA = N-methyl-D-aspartic  acid 
AMPA = -amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid 
LTD  =  Long term depotentiation 
LTP  =  Long term potentiation 
AGL  =  Artificial grammar learning 
MTL =  Medial  temporal  lobe 
VTA  =  Ventral tegmental area 
SRTT  =  Serial reachtion time task 
D1/D2  =  Dopamine 1/dopamine 2 receptor 
HVA =  Homovanillic  Acid 
SSRI  =  Selective serotonin reuptake inhibitor 
MDMA =  3,4-methylenedioxymethamphetamine 
BOLD  =  Blood oxygen level dependent 
FMRI  =  Functional magnetic resonance imaging 
BDNF  =  Brain derived neurotrophic factor 
EEG =  Electroencephalography 
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